Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,878,147 $ 4,992,145
Investments 17,219,179 21,253,866
Vendor receivable 173,499
Prepaid expenses and other current assets 1,068,133 527,380
Total current assets 21,165,459 26,946,890
Property and equipment, net 196,181 260,612
Intangible assets, net 18,696 19,309
Other assets 76,596 69,620
Total assets 21,456,932 27,296,431
Current liabilities:    
Accounts payable 308,605 371,993
Accrued liabilities 76,666 196,020
Accrued payroll and other compensation 358,572 754,314
Note payable, net of debt discount and offering costs of $0 and $8,723 as of June 30, 2022 and December 31, 2021, respectively 366,277
Total liabilities 743,843 1,688,604
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, Authorized 5,000,000 shares; No shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value, Authorized 180,000,000 shares; Issued and outstanding 86,981,684 shares as of June 30, 2022 and 86,339,567 as of December 31, 2021 86,982 86,340
Additional paid-in capital 111,346,910 110,255,549
Accumulated deficit (90,720,803) (84,734,062)
Total stockholders’ equity 20,713,089 25,607,827
Total liabilities and stockholders’ equity $ 21,456,932 $ 27,296,431